Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Wiggins

Showing results (341-350 of 351) with videos related to

Pageof 36
Sort By:
Nature Genetics|November 7, 2006
Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversibleBernward Hinkes, Roger C Wiggins, Rasheed Gbadegesin, et al.
The Journal of Clinical Investigation|June 12, 2020
Early safety indicators of COVID-19 convalescent plasma in 5000 patientsMichael J Joyner, R Scott Wright, DeLisa Fairweather, et al.
The Journal of Clinical Investigation|November 26, 2013
ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruptionShazia Ashraf, Heon Yung Gee, Stephanie Woerner, et al.
Medrxiv : the Preprint Server for Health Sciences|August 21, 2020
Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three-Month ExperienceMichael J Joyner, Jonathon W Senefeld, Stephen A Klassen, et al.
Medrxiv : the Preprint Server for Health Sciences|April 14, 2021
Program and patient characteristics for the United States Expanded Access Program to COVID-19 convalescent plasmaJonathon W Senefeld, Patrick W Johnson, Katie L Kunze, et al.
The New England Journal of Medicine|February 1, 2021
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19Michael J Joyner, Rickey E Carter, Jonathon W Senefeld, et al.
The Journal of Clinical Investigation|May 5, 2011
COQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafnessSaskia F Heeringa, Gil Chernin, Moumita Chaki, et al.
Mayo Clinic Proceedings|August 31, 2020
Safety Update: COVID-19 Convalescent Plasma in 20,000 Hospitalized PatientsMichael J Joyner, Katelyn A Bruno, Stephen A Klassen, et al.
Nature Communications|August 12, 2021
Mortality in individuals treated with COVID-19 convalescent plasma varies with the geographic provenance of donorsKatie L Kunze, Patrick W Johnson, Noud van Helmond, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|October 20, 2023
Rates Among Hospitalized Patients With COVID-19 Treated With Convalescent Plasma: A Systematic Review and Meta-AnalysisJonathon W Senefeld, Ellen K Gorman, Patrick W Johnson, et al.
Pageof 36

Showing results (341-350 of 351) with videos related to

Sort By:
Pageof 36
Nature Genetics|November 7, 2006
Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversibleBernward Hinkes, Roger C Wiggins, Rasheed Gbadegesin, et al.
The Journal of Clinical Investigation|June 12, 2020
Early safety indicators of COVID-19 convalescent plasma in 5000 patientsMichael J Joyner, R Scott Wright, DeLisa Fairweather, et al.
The Journal of Clinical Investigation|November 26, 2013
ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruptionShazia Ashraf, Heon Yung Gee, Stephanie Woerner, et al.
Medrxiv : the Preprint Server for Health Sciences|August 21, 2020
Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three-Month ExperienceMichael J Joyner, Jonathon W Senefeld, Stephen A Klassen, et al.
Medrxiv : the Preprint Server for Health Sciences|April 14, 2021
Program and patient characteristics for the United States Expanded Access Program to COVID-19 convalescent plasmaJonathon W Senefeld, Patrick W Johnson, Katie L Kunze, et al.
The New England Journal of Medicine|February 1, 2021
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19Michael J Joyner, Rickey E Carter, Jonathon W Senefeld, et al.
The Journal of Clinical Investigation|May 5, 2011
COQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafnessSaskia F Heeringa, Gil Chernin, Moumita Chaki, et al.
Mayo Clinic Proceedings|August 31, 2020
Safety Update: COVID-19 Convalescent Plasma in 20,000 Hospitalized PatientsMichael J Joyner, Katelyn A Bruno, Stephen A Klassen, et al.
Nature Communications|August 12, 2021
Mortality in individuals treated with COVID-19 convalescent plasma varies with the geographic provenance of donorsKatie L Kunze, Patrick W Johnson, Noud van Helmond, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|October 20, 2023
Rates Among Hospitalized Patients With COVID-19 Treated With Convalescent Plasma: A Systematic Review and Meta-AnalysisJonathon W Senefeld, Ellen K Gorman, Patrick W Johnson, et al.
Pageof 36